Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients
Jan J. De Waele(Ghent University Hospital), Jason A. Roberts(Queensland Health), Maija Kaukonen(Helsinki University Hospital), Andrew Udy(The Alfred Hospital), Matteo Bassetti(Ospedale Policlinico San Martino), Jordi Rello(Vall d'Hebron Hospital Universitari), Steven C. Wallis(The University of Queensland), Murat Akova(Hacettepe University), Philippe Montravers(Université Claude Bernard Lyon 1), Jeffrey Lipman(Queensland Health), Andrew Rhodes(Zoetis (United States)), Therese Starr(The University of Queensland), C. Martín(Hôpital Nord), Despoina Koulenti(University of Thessaly)
Cited by 180
Related Papers
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k